Eventful weekend at <a href='https://www.linkedin.com/feed/hashtag/?keywords=HRS2025&highlightedUpda…; target='_blank'>#HRS2025</a>! From new data like DEEP, to meaningful conversations with EPs and HCPs about the latest advancements in Afib treatment, it was an impactful few days. Thank you to everyone who stopped by!

Attention medical device sales professionals – we’re hiring! Join a rapidly growing organization committed to advancing patient care. Our sales team works alongside physicians in the operating room or labs, providing expert guidance to enhance product utilization and patient outcomes. ​

If you're ready to make a difference, check out our open positions and apply today!​

<a href="https://okt.to/Vla4W0&quot; target="_blank">https://okt.to/Vla4W0</a&gt;
​
<a href='https://www.linkedin.com/feed/hashtag/?keywords=Hiring&highlightedUpdat…; target='_blank'>#Hiring</a>

Dr. Jayanthi Koneru presented the DEEP abstract results today at <a href="https://twitter.com/hashtag/HRS2025?src=hashtag_click&quot; target="_blank">#HRS2025</a>, showcasing the long-term effectiveness and durability of Hybrid Ablation in treating Advanced Afib patients.

Dr. Jayanthi Koneru presented the DEEP abstract results today at <a href='https://www.linkedin.com/feed/hashtag/?keywords=HRS2025&highlightedUpda…; target='_blank'>#HRS2025</a>, showcasing the long-term effectiveness and durability of Hybrid Ablation in treating Advanced Afib patients.

The DEEP Trial revealed that 71.6% of patients with Advanced Afib disease* had no recurring atrial arrhythmias** one year after the procedure, and 62.4% remained arrhythmia-free two years post-procedure.

*Persistent or long-standing persistent Afib
**Afib, atrial flutter, atrial tachycardia episodes >30 sec, off anti-arrhythmic drugs (AAD, if reported) and regardless of AAD status.

The AtriClip® device portfolio provides versatile options for both MIS and open procedures for LAAE. Whether you need a standard or low-profile solution, we have options designed for complete closure.

Stop by Booth 915 at <a href="https://twitter.com/hashtag/HRS2025?src=hashtag_click&quot; target="_blank">#HRS2025</a> to explore our full range! ​

Important Safety

The AtriClip® device portfolio provides versatile options for both MIS and open procedures for left atrial appendage exclusion (LAAE). Whether you need a standard or low-profile solution, we have options designed for complete closure. ​

Stop by Booth 915 at <a href='https://www.linkedin.com/feed/hashtag/?keywords=HRS2025&highlightedUpda…; target='_blank'>#HRS2025</a> to explore our full range! ​

Important Safety Information: <a href="https://okt.to/83Lskg&quot; target="_blank">https://okt.to/83Lskg</a&gt; ​

Dr. DJ Lakkireddy shared valuable insights at <a href="https://twitter.com/hashtag/HRS2025?src=hashtag_click&quot; target="_blank">#HRS2025</a> about a national survey conducted among 146 non-cardiologists and general cardiologists across the U.S. The purpose was to determine their familiarity with symptomatic inappropriate sinus tachycardia (IST) and available

Dr. Dhanunjaya (DJ) Lakkireddy MD, MBA shared valuable insights at <a href='https://www.linkedin.com/feed/hashtag/?keywords=HRS2025&highlightedUpda…; target='_blank'>#HRS2025</a> about a national survey conducted among 146 non-cardiologists and general cardiologists across the U.S. The purpose was to determine their familiarity with symptomatic inappropriate sinus tachycardia (IST) and available treatment options. Although awareness of IST was low, more than half of cardiologists and general practitioners said they encounter IST patients regularly.

We're passionately focused on the continued innovation and science behind our AtriClip® device portfolio. With over 600,000 devices implanted and more than 90 studies, we’re setting the gold standard to surgical LAAE.​

Stop by booth 915 at <a href="https://twitter.com/hashtag/HRS2025?src=hashtag_click&quot; target="_blank">#HRS2025</a> to see the latest

At AtriCure, we’re passionately focused on the continued innovation and science behind our AtriClip® device portfolio. With over 600,000 devices implanted and more than 90 studies, we’re setting the gold standard to surgical LAAE.​

Stop by booth 915 at <a href='https://www.linkedin.com/feed/hashtag/?keywords=HRS2025&highlightedUpda…; target='_blank'>#HRS2025</a> to see the latest AtriClip device innovation.